Telix Pharmaceuticals Ltd (OTCPK:TLPPF)
$ 10.3 -0.51 (-4.72%) Market Cap: 3.35 Bil Enterprise Value: 3.44 Bil PE Ratio: 936.36 PB Ratio: 32.19 GF Score: 78/100

Q3 2023 Telix Pharmaceuticals Ltd Activities Report Call Transcript

Oct 18, 2023 / 09:30PM GMT
Release Date Price: $6.57 (+2.82%)
Operator

Good day, and thank you for standing by. Welcome to the Telix Q3, 2023 Results and Business Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Kyahn Williamson, SVP of Investor Relations and Corporate Communications. Please go ahead.

Kyahn Williamson
Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR

Thanks so much, Maggie, and thank you, everybody, for joining us today. So, before we kick off, I'd like to just point out that we've literally just launched an interim readout from our ProstACT SELECT study, after receiving the finalized clinical data overnight. So, appreciate that people won't have had time to have read through that, we will include some snapshots of that presentation in today's slides.

So, I just firstly want to introduce the speakers. Joining me today, we have Dr. Christian Behrenbruch, our Group CEO and Managing Director; Dr. Colin Hayward, our Group Chief Commercial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot